Keyphrases
Combretastatin A4 Phosphate (CA4P)
82%
Degradation Products
73%
Isocyanide
64%
Chemical Stability
63%
Metabolic Stability
61%
Novel Class
56%
Metabolic Fate
48%
Store-operated Calcium Entry
44%
Nicotinamide Phosphoribosyltransferase (NAMPT)
44%
Biological Evaluation
44%
Metabolism
44%
Triazole
41%
In Vitro Metabolism
37%
Pharmacophoric Group
37%
Medicinal Chemistry
36%
Forced Degradation Studies
36%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
36%
Indoleamine 2,3-dioxygenase 1 (IDO1)
36%
Prodrug
33%
Medicinal Chemist
30%
Thiocolchicoside
29%
Arynes
29%
1,2,3-triazole
29%
Synthetic Evaluation
29%
Metabolism Study
29%
Drug-like
29%
Antitubulin Agents
29%
Reactive Metabolites
29%
HPLC-UV Method
29%
Oxybutynin
29%
Acute Pancreatitis
29%
Propargylamines
29%
Stability Indicating HPLC
29%
Alizapride
29%
Human Liver Microsomes
29%
Soft Drugs
25%
Regioselectivity
24%
Pharmacokinetic Profile
22%
Rat Liver Microsomes
21%
Tubulin
21%
Epoxides
20%
Drug Substance
19%
Impurities
19%
LC-UV Method
19%
Antiproliferative Activity
19%
Anti-inflammatory Activity
19%
Amides
19%
Enaminoketones
19%
Stability Study
19%
Cytotoxicity
19%
Pharmacology, Toxicology and Pharmaceutical Science
Combretastatin A4
59%
Isocyanide
59%
Tubulin
58%
Triazole
55%
Combretastatin
49%
Malignant Neoplasm
48%
Nicotinamide Phosphoribosyltransferase
44%
Pharmacodynamics
42%
High Performance Liquid Chromatography
42%
Pharmaceutical Chemistry
40%
Disease
35%
Quinone Derivative
34%
Chemical Stability
33%
Pharmacokinetics
32%
Thiocolchicoside
29%
Prodrug
29%
Acute Pancreatitis
29%
Alizapride
29%
Kynurenine
29%
Clinical Trial
24%
Tryptophan
23%
Inflammation
23%
Oxybutynin
22%
Asthma
22%
Cytotoxicity
21%
Epoxide
20%
Antiproliferative Activity
19%
Triazole Derivative
19%
Mesothelioma
19%
Antiinflammatory Activity
19%
Electrospray Ionization
19%
Antiinfective Agent
19%
Fusion Inhibitor
17%
Biodistribution
16%
Functional Groups
16%
Carboxylate
15%
Skin Disease
14%
Pantethine
14%
Neovascularization (Pathology)
14%
Nerve Degeneration
14%
Doxofylline
14%
Cell Culture
14%
Oxadiazole Derivative
14%
Aldehyde Dehydrogenase
14%
Pyrazole Derivative
14%
Rutin
14%
Vanilloid Receptor 1
14%
Dioxygenase
14%
Phosphatidylinositol 3 Kinase
14%
Tryptophan 2,3 Dioxygenase
14%
Chemistry
stability
100%
Degradation Product
81%
Metabolic
47%
formation
36%
Tandem Mass Spectrometry
33%
Chemical Stability
33%
1,2,3-triazole
29%
Metabolite
29%
High Performance Liquid Chromatography
29%
Chemistry
20%
Electrospray Ionization
18%
Passerini Condensation
18%
Pharmacokinetics
17%
Mobile Phase Composition
17%
Pantethine
14%
Nicotinamide
14%
Cannabigerol
14%
Mass Spectrometry
14%
Isocyanide
14%
Rutin
14%
Proteolysis Targeting Chimera
14%
Semicarbazide Hydrochloride
14%
Carbazochrome Sodium Sulfonate
14%
Carbazochrome
14%
Carboxamide
14%
Aryne
14%
Cascade Reaction
14%
Transition Metal
14%
Flavonoid
14%
Suzuki Reaction
14%
Culture Media
14%
Nitrogen Dioxide
14%
Disulfide
14%
4-Phenylbutyric Acid
14%
Endocannabinoid
14%
Vanilloid
14%
Cannabinoid
14%
Liquid Chromatography Mass Spectrometry
11%
Antitubulinic
11%
Quinone
10%
Enzymatic Hydrolysis
10%
Acetamide
9%
Tetrahydropyran
9%
Formamide
9%
Dosage Forms
9%
Buffer Solution
9%
hydrolytic
9%
Flow Kinetics
9%
Quercetin
8%
Table Salt
7%
